Lander L - Search Results

1

Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.

Zheng W, Nickasch M, Lander L, Wen S, Xiao M, Marshalek P, Dix E, Sullivan C. Zheng W, et al. Among authors: lander l. J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287. J Addict Med. 2017. PMID: 28107210 Free PMC article.

2

The changing face of opioid addiction: prescription pain pill dependence and treatment.

Byrne MH, Lander L, Ferris M. Byrne MH, et al. Among authors: lander l. Health Soc Work. 2009 Feb;34(1):53-6. doi: 10.1093/hsw/34.1.53. Health Soc Work. 2009. PMID: 19281102 No abstract available.

3

Preliminary evaluation of the WV Prescription Drug Abuse Ouitline.

Zullig KJ, Lander L, White RJ, Sullivan C, Shockley C, Dong L, Pack RP, Fedis TS. Zullig KJ, et al. Among authors: lander l. W V Med J. 2010;106(4 Spec No):38-46. W V Med J. 2010. PMID: 21932752

4

Rural healthcare disparities: challenges and solutions for the pregnant opioid-dependent population.

Lander LR, Marshalek P, Yitayew M, Ford D, Sullivan CR, Gurka KK. Lander LR, et al. W V Med J. 2013 Jul-Aug;109(4):22-7. W V Med J. 2013. PMID: 23930558

5

Guidelines for the Management of Pregnant Women With Substance Use Disorders.

McLafferty LP, Becker M, Dresner N, Meltzer-Brody S, Gopalan P, Glance J, Victor GS, Mittal L, Marshalek P, Lander L, Worley LL. McLafferty LP, et al. Among authors: lander l. Psychosomatics. 2016 Mar-Apr;57(2):115-30. doi: 10.1016/j.psym.2015.12.001. Epub 2015 Dec 3. Psychosomatics. 2016. PMID: 26880374 Review.

6

Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population.

Zheng WH, Wakim RJ, Geary RC, Lander LR, Wen SJ, Xiao MC, Sullivan CR. Zheng WH, et al. Among authors: lander lr. Austin J Drug Abuse Addict. 2016;3(1):1009. Epub 2016 Jul 25. Austin J Drug Abuse Addict. 2016. PMID: 28133635 Free PMC article.

7

Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.

Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE. Nguyen L, et al. Among authors: lander lr. Am J Addict. 2018 Mar;27(2):92-96. doi: 10.1111/ajad.12687. Epub 2018 Feb 23. Am J Addict. 2018. PMID: 29473258 Free PMC article.

8

Yoga as an Adjunctive Intervention to Medication-Assisted Treatment with Buprenorphine+Naloxone.

Lander L, Chiasson-Downs K, Andrew M, Rader G, Dohar S, Waibogha K. Lander L, et al. J Addict Res Ther. 2018;9(1):354. doi: 10.4172/2155-6105.1000354. Epub 2017 Dec 10. J Addict Res Ther. 2018. PMID: 30820364 Free PMC article.

9

Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Kaski SW, Brooks S, Wen S, Haut MW, Siderovski DP, Berry JH, Lander LR, Setola V. Kaski SW, et al. J Opioid Manag. 2019 Mar-Apr;15(2):103-109. doi: 10.5055/jom.2019.0491. J Opioid Manag. 2019. PMID: 31057342 Free PMC article.

10

West Virginia's model of buprenorphine expansion: Preliminary results.

Winstanley EL, Lander LR, Berry JH, Mahoney JJ 3rd, Zheng W, Herschler J, Marshalek P, Sayres S, Mason J, Haut MW. Winstanley EL, et al. Among authors: lander lr. J Subst Abuse Treat. 2020 Jan;108:40-47. doi: 10.1016/j.jsat.2019.05.005. Epub 2019 May 8. J Subst Abuse Treat. 2020. PMID: 31221524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters